EVAX
Evaxion AS
NASDAQ · Healthcare · Biotechnology · DK
$2.97
+0.34%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 105.00x
- P/S forward
- 64.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.81x
- Price / sales
- 3.58x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $19.9M
- EV / sales
- 2.66x
- EV / EBITDA
- -2.00x
- EV / EBIT
- -2.29x
- Market cap
- $26.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026